Welcome to LookChem.com Sign In|Join Free

CAS

  • or

58-94-6

Post Buying Request

58-94-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58-94-6 Usage

Description

Chlorothiazide is a first-in-class thiazide diuretic initially discovered from its ability to inhibit carbonic anhydrase in vitro. As an antihypertensive agent, this thiazide increases renal excretion of sodium, potassium, chloride, and bicarbonate ions by inhibiting tubular reabsorptive mechanisms.

Chemical Properties

Off-White Solid

Originator

Diuril,Merck Sharp and,US,1957

Uses

Different sources of media describe the Uses of 58-94-6 differently. You can refer to the following data:
1. This drug exhibits strong diuretic action during both acidosis and alkalosis. It is used for arterial hypertension, in edematous syndromes of various genesis, congestive effects in cardiovascular insufficiency, nephrosis and nephritis, and toxicosis. It is especially recommended for hypertonic illnesses. It lowers intraocular pressure in a number of cases.
2. Diuretic; antihypertensive. Hydrochlorothiazide EP Impurity A.

Definition

ChEBI: 4H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position is substituted by chlorine and that at position 7 is substituted by a sulfonamide group. A diuretic, it is used for treatment of oedema and hypertension.

Manufacturing Process

(A) m-Chloroaniline (64 g, 0.5 mol) was added dropwise with stirring to 375 ml of chlorosulfonic acid in a 3-liter round bottom, 3-necked flask cooled in an ice bath. Sodium chloride (350 g) was added portionwise over a period of 1 to2 hours and the mixture then heated gradually in an oil bath to 150°C. After 3 hours at 150° to 160°C, the flask was cooled thoroughly in an ice bath and the contents treated with a liter of cold water. The product was extracted with ether and the extract washed with water and dried over sodium sulfate. After removal of ether on the steam bath, the residual 5-chloroaniline-2,4- disulfonyl chloride, which may be crystallized from benzene-hexane MP 130° to 132°C, was cooled in an ice bath and treated with 150 ml of 28% ammonium hydroxide in a 2-liter Erlenmeyer flask. The mixture was heated on the steam bath for 1 hour, cooled and the product collected on the filter, washed with water and dried. Upon crystallization from dilute alcohol 5- chloro-2,4-disulfamylaniline was obtained as colorless needles, MP 251° to 252°C. (B) A solution of 88 g of 5-chloro-2,4-disulfamylaniline in 1.1 liters of 88% formic acid was heated under reflux for 2 hours. After removal of 200 ml of solvent by distillation, one liter of water was added and the product collected, washed with water and dried. Crystallization from dilute alcohol afforded 6- chloro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide as colorless needles, MP 342.5° to 343°C, as described in US Patent 2,809,194.

Brand name

Diuril (Ovation).

Therapeutic Function

Diuretic; Antihypertensive

General Description

Crystals; white powder.

Air & Water Reactions

Insoluble in water.

Reactivity Profile

Alkaline aqueous solutions will decompose on standing or heating .

Fire Hazard

Flash point data for Chlorothiazide are not available; however, Chlorothiazide is probably combustible.

Mechanism of action

The diuretic action of chlorothiazide, like other drugs of this series, is caused by reduced absorption of sodium and chloride ions by the kidneys during their simultaneous, intense excretion from the organism.

Safety Profile

Moderately_toxic by intraperitoneal and intravenous routes. Mddly toxic by ingestion. Experimental reproductive effects. Has been implicated in aplastic anemia. When heated to decomposition it emits very toxic fumes of SOx NOx and Cl-.

Synthesis

Chlorothiazide, 1,1-dioxide 6-chloro-2H-1,2,4-benzothiadiazin-7-sulfonamide (21.3.3) is synthesized in the exact same manner, is all thiazide diuretics. 3- Chloroaniline (or 3-trifluoromethylaniline) undergoes sulfoylchlorination by chlorosulfonic acid, forming 4,6-sulfonochloride-3-chloroaniline (21.3.1), the reaction of which with ammonia gives 4,6-sulfonylamido-3-chloroaniline (21.3.2). Heating this with formamide leads to formation of chlorothiazide (21.3.3).

Veterinary Drugs and Treatments

In veterinary medicine, furosemide has largely supplanted the use of thiazides as a general diuretic (edema treatment). Thiazides are still used for the treatment of systemic hypertension, nephrogenic diabetes insipidus, and to help prevent the recurrence of calcium oxalate uroliths in dogs. Chlorothiazide is approved for use in dairy cattle for the treatment of post parturient udder edema, but the veterinary labeled product has been discontinued in the USA.

Check Digit Verification of cas no

The CAS Registry Mumber 58-94-6 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 8 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 58-94:
(4*5)+(3*8)+(2*9)+(1*4)=66
66 % 10 = 6
So 58-94-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H6ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-3H,(H2,9,12,13)(H,10,11,14,15)

58-94-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (PHR1179)  Chlorothiazide  pharmaceutical secondary standard; traceable to USP, PhEur and BP

  • 58-94-6

  • PHR1179-500MG

  • 732.19CNY

  • Detail
  • Sigma-Aldrich

  • (C1700000)  Chlorothiazide  European Pharmacopoeia (EP) Reference Standard

  • 58-94-6

  • C1700000

  • 1,880.19CNY

  • Detail
  • USP

  • (1121005)  Chlorothiazide  United States Pharmacopeia (USP) Reference Standard

  • 58-94-6

  • 1121005-200MG

  • 4,662.45CNY

  • Detail

58-94-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name chlorothiazide

1.2 Other means of identification

Product number -
Other names 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-, 1,1-dioxide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58-94-6 SDS

58-94-6Synthetic route

chloraminophenamide
121-30-2

chloraminophenamide

formic acid
64-18-6

formic acid

chlorothiazide
58-94-6

chlorothiazide

Conditions
ConditionsYield
at 90 - 100℃; for 5h;
chlorothiazide
58-94-6

chlorothiazide

6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
58-93-5

6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide

Conditions
ConditionsYield
With potassium borohydride; acetic acid In methanol at -10 - 5℃; for 4h; Reagent/catalyst; Solvent;93.9%
With hydrogen; platinum(IV) oxide In ethanol
butanoic acid anhydride
106-31-0

butanoic acid anhydride

chlorothiazide
58-94-6

chlorothiazide

6-chloro-1,1-dioxo-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid butyrylamide
94628-06-5

6-chloro-1,1-dioxo-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid butyrylamide

Conditions
ConditionsYield
In pyridine
chlorothiazide
58-94-6

chlorothiazide

acetic anhydride
108-24-7

acetic anhydride

6-chloro-1,1-dioxo-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid acetylamide
5059-53-0

6-chloro-1,1-dioxo-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid acetylamide

Conditions
ConditionsYield
In pyridine
chlorothiazide
58-94-6

chlorothiazide

allyl bromide
106-95-6

allyl bromide

4-allyl-6-chloro-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide
103564-56-3

4-allyl-6-chloro-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide

Conditions
ConditionsYield
(i) Na, EtOH, (ii) /BRN= 605308/; Multistep reaction;
chlorothiazide
58-94-6

chlorothiazide

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

4-amino-6-chloro-benzene-1,3-disulfonic acid 1-amide 3-ethylamide
1668-63-9

4-amino-6-chloro-benzene-1,3-disulfonic acid 1-amide 3-ethylamide

Conditions
ConditionsYield
(i), (ii) aq. iPrOH; Multistep reaction;
chlorothiazide
58-94-6

chlorothiazide

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

6-chloro-4-ethyl-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide
1668-62-8

6-chloro-4-ethyl-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide

chlorothiazide
58-94-6

chlorothiazide

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

N-(6-chloro-1,1-dioxo-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonyl)-formimidic acid ethyl ester
92971-42-1

N-(6-chloro-1,1-dioxo-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonyl)-formimidic acid ethyl ester

chlorothiazide
58-94-6

chlorothiazide

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

N-(6-chloro-4-ethyl-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonyl)-formimidic acid ethyl ester
1668-61-7

N-(6-chloro-4-ethyl-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonyl)-formimidic acid ethyl ester

chlorothiazide
58-94-6

chlorothiazide

dimethyl sulfate
77-78-1

dimethyl sulfate

6-chloro-1,1-dioxo-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid methylamide
90434-33-6

6-chloro-1,1-dioxo-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid methylamide

Conditions
ConditionsYield
With sodium hydroxide
chlorothiazide
58-94-6

chlorothiazide

dimethyl sulfate
77-78-1

dimethyl sulfate

6-chloro-4-methyl-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide
90434-34-7

6-chloro-4-methyl-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide

Conditions
ConditionsYield
With sodium hydroxide
chlorothiazide
58-94-6

chlorothiazide

thiophenol
108-98-5

thiophenol

4-amino-6-phenylsulfanyl-benzene-1,3-disulfonic acid diamide
37531-26-3

4-amino-6-phenylsulfanyl-benzene-1,3-disulfonic acid diamide

Conditions
ConditionsYield
(i) aq. NaHCO3, (ii) aq. NaOH; Multistep reaction;
chlorothiazide
58-94-6

chlorothiazide

6-chloro-1,1-dioxo-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid formimidoylamide
100048-05-3

6-chloro-1,1-dioxo-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid formimidoylamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: NH3
View Scheme
chlorothiazide
58-94-6

chlorothiazide

1,1-dioxo-6-phenylsulfanyl-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide
34919-71-6

1,1-dioxo-6-phenylsulfanyl-1,2(4)-dihydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: (i) aq. NaHCO3, (ii) aq. NaOH
2: Heating
View Scheme
chlorothiazide
58-94-6

chlorothiazide

1,1-dioxo-6-phenylsulfanyl-1,2,3,4-tetrahydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide
37531-27-4

1,1-dioxo-6-phenylsulfanyl-1,2,3,4-tetrahydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: (i) aq. NaHCO3, (ii) aq. NaOH
2: aq. TsOH / methanol / Heating
View Scheme
chlorothiazide
58-94-6

chlorothiazide

3-benzyl-1,1-dioxo-6-phenylsulfanyl-1,2,3,4-tetrahydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide
34919-72-7

3-benzyl-1,1-dioxo-6-phenylsulfanyl-1,2,3,4-tetrahydro-1λ6-benzo[1,2,4]thiadiazine-7-sulfonic acid amide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: (i) aq. NaHCO3, (ii) aq. NaOH
2: aq. AcOH / methanol / Heating
View Scheme
chlorothiazide
58-94-6

chlorothiazide

chlorothiazide sodium

chlorothiazide sodium

Conditions
ConditionsYield
With sodium hydroxide In ethanol at 25 - 65℃; Product distribution / selectivity;
4,4'-bipyridine
553-26-4

4,4'-bipyridine

chlorothiazide
58-94-6

chlorothiazide

C7H6ClN3O4S2*0.5C10H8N2

C7H6ClN3O4S2*0.5C10H8N2

Conditions
ConditionsYield
In acetone at 20℃;
chlorothiazide
58-94-6

chlorothiazide

trans-1,2-bis(4-pyridyl)ethylene
1135-32-6

trans-1,2-bis(4-pyridyl)ethylene

C7H6ClN3O4S2*C12H10N2

C7H6ClN3O4S2*C12H10N2

Conditions
ConditionsYield
In acetone at 20℃;
1,3-di(4-pyridyl)propane
17252-51-6

1,3-di(4-pyridyl)propane

chlorothiazide
58-94-6

chlorothiazide

C7H6ClN3O4S2*2C13H14N2

C7H6ClN3O4S2*2C13H14N2

Conditions
ConditionsYield
In acetone at 20℃;
hexamethylenetetramine
100-97-0

hexamethylenetetramine

chlorothiazide
58-94-6

chlorothiazide

C7H6ClN3O4S2*C6H12N4

C7H6ClN3O4S2*C6H12N4

Conditions
ConditionsYield
In acetonitrile at 20℃;
chlorothiazide
58-94-6

chlorothiazide

benzamide
55-21-0

benzamide

C7H6ClN3O4S2*C7H7NO

C7H6ClN3O4S2*C7H7NO

Conditions
ConditionsYield
In acetone at 20℃;
carbamazepin
298-46-4

carbamazepin

chlorothiazide
58-94-6

chlorothiazide

2C7H6ClN3O4S2*4C15H12N2O

2C7H6ClN3O4S2*4C15H12N2O

Conditions
ConditionsYield
In acetone at 20℃;
chlorothiazide
58-94-6

chlorothiazide

nicotinamide
98-92-0

nicotinamide

C7H6ClN3O4S2*C6H6N2O

C7H6ClN3O4S2*C6H6N2O

Conditions
ConditionsYield
In acetonitrile at 20℃;
isonicotinamide
1453-82-3

isonicotinamide

chlorothiazide
58-94-6

chlorothiazide

C7H6ClN3O4S2*C6H6N2O

C7H6ClN3O4S2*C6H6N2O

Conditions
ConditionsYield
In acetonitrile at 20℃;
chlorothiazide
58-94-6

chlorothiazide

benzamidin
618-39-3

benzamidin

C7H6ClN3O4S2*C7H8N2

C7H6ClN3O4S2*C7H8N2

Conditions
ConditionsYield
In acetonitrile at 4℃;

58-94-6Relevant articles and documents

Synthesis, characterization, and investigation of the antioxidant activity of some 1,2,4-benzothiadiazine-1,1-dioxides bearing sulfonylthioureas moieties

Harrouche, Kamel,Lahouel, Asma,Belghobsi, Mebrouk,Pirotte, Bernard,Khelili, Smail

, p. 824 - 832 (2019/11/28)

A series of 1,2,4-benzothiadiazine-1,1-dioxides bearing a sulfonylthiourea moiety were synthesized, characterized, and screened for their antioxidant activity, using six antioxidant analytical assays comparatively to reference compounds, ascorbic acid and quercetin. The results indicated that several compounds demonstrated strong antioxidant activity in DPPH, ABTS, H2O2, and lipid peroxidation assays where some of them were either as active as or more active than reference compounds. However, all compounds were largely less active than references compounds in the reducing power assay. The results indicated that the thiourea moiety probably played a crucial role in the antioxidant activity of the target compounds, as a thiolate ion. The most favorable R1 groups were the hydrogen atom and methyl group, followed by phenyl and benzyl groups, whereas the most favorable R2 group was iPr, followed by the phenyl and methyl groups. The combination of benzothiadiazine ring with sulfonylthiourea moieties led to valuable new antioxidants, which could be used in the treatment or the prevention of certain diseases or in the field of cosmetics, which needs further investigations in the future.

Synthesis and pharmacological evaluation of 1,2,4-benzothiadiazin-1,1- dioxides bearing 5- or 7-sulfonylurea moieties

Khelili, Smail,Faury, Gilles,Nicolle, Edwige,Verdetti, Jean,Leclerc, Gerard

, p. 457 - 470 (2007/10/03)

A series of substituted benzothiadiazin-1,1-dioxides bearing sulfonylurea moieties in position 5 or 7 has been synthesized. The most powerful vasodilator compound was 18a, obtained by substitution of a sulfonylurea moiety on position 7 of the diazoxide skeleton by means of a SO2 group. Interestingly, 18a and 18b were found inactive on insulin secretion at 50 μM and likely devoid of adverse effect on glycemia, suggesting a special therapeutic potential for these compounds.

STUDIES ON THE STABILITY OF DRUGS. XII. STABILITY OF BENZOTHIADIAZINES.

YAMANA,MIZUKAMI,ICHIMURA,KOIKE

, p. 974 - 976 (2007/10/13)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 58-94-6